Yanchao Xu

Nanjing, 210008, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Histone delactylation shapes epigenetic landscapes and therapeutic stratification in hepatocellular carcinoma.

Histone delactylation shapes epigenetic landscapes and therapeutic stratification in hepatocellular carcinoma.

Journal: iLIVER

Published: December 09, 2025

Intratumoral Proton Density Fat Fraction Predicts the Outcome of HAIC Combined With PD-1 Inhibitors in Advanced Hepatocellular Carcinoma.

Intratumoral Proton Density Fat Fraction Predicts the Outcome of HAIC Combined With PD-1 Inhibitors in Advanced Hepatocellular Carcinoma.

Journal: Cancer medicine

Published: November 11, 2025

Aberrant Cholesterol Metabolism Caused by Decreased Lecithin: Cholesterol Acyltransferase Promoted Hepatocarcinogenesis.

Aberrant Cholesterol Metabolism Caused by Decreased Lecithin: Cholesterol Acyltransferase Promoted Hepatocarcinogenesis.

Journal: Journal of hepatocellular carcinoma

Published: August 24, 2025

The Impact of Hepatitis B Virus on the Tumor Microenvironment of Hepatocellular Carcinoma and Therapeutic Strategies.

The Impact of Hepatitis B Virus on the Tumor Microenvironment of Hepatocellular Carcinoma and Therapeutic Strategies.

Journal: Journal of gastroenterology and hepatology

Published: June 07, 2025

Molecular stratification of hepatocellular carcinoma by metabolic-signaling pathways guides precision immunotherapy and TACE therapy.

Molecular stratification of hepatocellular carcinoma by metabolic-signaling pathways guides precision immunotherapy and TACE therapy.

Journal: Clinical and molecular hepatology

Published: March 27, 2025

PLAGL2 promotes HCC progression by recruiting tumour-associated macrophages via CCL2/CCR2 signalling.

PLAGL2 promotes HCC progression by recruiting tumour-associated macrophages via CCL2/CCR2 signalling.

Journal: British journal of pharmacology

Published: March 21, 2025

β-catenin mutation reprograms ketone body metabolism to drive hepatocellular carcinoma metastasis and resistance to ketogenic therapy via transcriptional activation of OXCT1.

β-catenin mutation reprograms ketone body metabolism to drive hepatocellular carcinoma metastasis and resistance to ketogenic therapy via transcriptional activation of OXCT1.

Journal: Cell death & disease

Published: March 20, 2025

The MHC-I-dependent neoantigen presentation pathway predicts response rate to PD-1/PD-L1 blockade.

The MHC-I-dependent neoantigen presentation pathway predicts response rate to PD-1/PD-L1 blockade.

Journal: Biomolecules & biomedicine

Published: July 31, 2024

NitraTh epitope-based neoantigen vaccines for effective tumor immunotherapy.

NitraTh epitope-based neoantigen vaccines for effective tumor immunotherapy.

Journal: Cancer immunology, immunotherapy : CII

Published: July 20, 2024

Letter to the Editor: Molecular classification based on multi-omics facilitates prognostic stratification and personalized treatment in hepatocellular carcinoma.

Letter to the Editor: Molecular classification based on multi-omics facilitates prognostic stratification and personalized treatment in hepatocellular carcinoma.

Journal: Hepatology (Baltimore, Md.)

Published: April 26, 2024

Liver Regeneration-Related Genes of Nontumor Liver Tissues Predict the Prognosis of Patients with Hepatocellular Carcinoma.

Liver Regeneration-Related Genes of Nontumor Liver Tissues Predict the Prognosis of Patients with Hepatocellular Carcinoma.

Journal: Journal of hepatocellular carcinoma

Published: September 08, 2023

β-Catenin Activation Reprograms Ammonia Metabolism to Promote Senescence Resistance in Hepatocellular Carcinoma.

β-Catenin Activation Reprograms Ammonia Metabolism to Promote Senescence Resistance in Hepatocellular Carcinoma.

Journal: Cancer research

Published: March 01, 2023

Showing 1-12 of 15

Last Updated: 09/26/2026